TCL Archive Tasigna Shows Benefit Over Gleevec In Phase III Study for Ph+ CML In Chronic Phase December 31, 2010
TCL Archive Three Cancer Centers Test Targeted Therapy For Resistant Acute Myelogenous Leukemia July 26, 2002